This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

Viral Vector Characterization & Analytical Development

115 115 people viewed this event.

In 2023, industry is witnessing a renaissance in viral vector characterization. Spurred by widespread biopharma investment to engineer a new wave of novel capsids and faced with newly launched QbD frameworks by US Pharmacopeia and the FDA’s tightened guidance, increased vector complexity is creating a new era for advanced analytical technologies to ensure precision and accuracy.

In the wake of significant collaborations including Vector Bio and iBET’s for high-throughput characterization, and the likes of Vertex and BMS announcing their priority to build out their internal analytical competencies, the inaugural Viral Vector Characterization & Analytical Development Summit arrives to pave the foundation for teams to further optimize process development and accelerate vector scale-up with GMP compliance in mind.

Time: 10:00 AM – 4:00 PM

Venue details: Hilton Boston/Woburn, 2 Forbes Road, Woburn, Massachusetts, 01801, United States

Event Organizer - Hanson Wade

Event Website
 

Date

25–27 September 2023
 

City

 

Country

United States of America
 

Topic Area

Health and Medicine

Share With Colleagues